GTC Biotherapeutics (fka GTCB)

[kris_kade]

What I don't understand, is with some of the good news baked in (including 50% on european profits), why the analysts have not increased their revenue forecast & pps yet ?

These idiots keep saying, every news is a POSITIVE development for GTCB but they cannot translate that to tangible forecast.

Street usually can smell a winner few quarters away especially if they think the model has bright future. For some reason, they are not which once again translates (I suspect) to same perception on behalf of big pharmas for any partnership.

Let's hope Dr. Gray can convince otherwise